The success of Boston Scientific's Taxus drug-eluting stent helped boost combination products' popularity. However, the regulatory requirements for such products are strict. Who Will Be the Lead ...

Marketing efforts take vastly different shapes in the pharmaceutical and medical device industries. In pharmaceutical marketing, product brands reign supreme, as demonstrated by household names such ...

Veteran leader in drug-device development, regulatory strategy, and global standards partners with EdgeOne to strengthen expertise as combination product complexity grows WHEELING, Ill., March 11, ...

Developing a drug delivery device system (combination product) adds a layer of complexity to your pharmaceutical program that many companies underestimate until it's too late. Success depends not just ...

Genus Medical Technologies, LLC v. FDA legal case leads to agency-wide review and reclassification of eye cups, eye droppers, and ophthalmic dispensers “While we were surprised by the FDA’s position ...

Abbott is a prominent key player in the global drug device combination products market. Abbott's Medical Devices segment delivers a combination of products, particularly in high-impact areas such as ...

WINDSOR, Conn., Aug. 9, 2022 — Total new premium for individual life combination products increased 22% to $4.3 billion, compared with prior year results, and down slightly from the $4.8 billion in ...

A new combination product comprising the triptan rizatriptan and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam has shown promising results in the treatment of migraine. In the phase 3 ...

After three consecutive years of growth, total new premium for individual life combination products dropped 2% to $4.3 billion in 2018, according to LIMRA’s 2018 Individual Life Combination Products ...